Splice site mutations in the ATP7A gene.

Menkes disease (MD) is caused by mutations in the ATP7A gene. We describe 33 novel splice site mutations detected in patients with MD or the milder phenotypic form, Occipital Horn Syndrome. We review these 33 mutations together with 28 previously published splice site mutations. We investigate 12 mu...

Full description

Bibliographic Details
Main Authors: Tina Skjørringe, Zeynep Tümer, Lisbeth Birk Møller
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-04-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3073976?pdf=render
id doaj-16383d40f4644cdaa18427b801bfbe55
record_format Article
spelling doaj-16383d40f4644cdaa18427b801bfbe552020-11-25T02:23:38ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-04-0164e1859910.1371/journal.pone.0018599Splice site mutations in the ATP7A gene.Tina SkjørringeZeynep TümerLisbeth Birk MøllerMenkes disease (MD) is caused by mutations in the ATP7A gene. We describe 33 novel splice site mutations detected in patients with MD or the milder phenotypic form, Occipital Horn Syndrome. We review these 33 mutations together with 28 previously published splice site mutations. We investigate 12 mutations for their effect on the mRNA transcript in vivo. Transcriptional data from another 16 mutations were collected from the literature. The theoretical consequences of splice site mutations, predicted with the bioinformatics tool Human Splice Finder, were investigated and evaluated in relation to in vivo results. Ninety-six percent of the mutations identified in 45 patients with classical MD were predicted to have a significant effect on splicing, which concurs with the absence of any detectable wild-type transcript in all 19 patients investigated in vivo. Sixty-seven percent of the mutations identified in 12 patients with milder phenotypes were predicted to have no significant effect on splicing, which concurs with the presence of wild-type transcript in 7 out of 9 patients investigated in vivo. Both the in silico predictions and the in vivo results support the hypothesis previously suggested by us and others, that the presence of some wild-type transcript is correlated to a milder phenotype.http://europepmc.org/articles/PMC3073976?pdf=render
collection DOAJ
language English
format Article
sources DOAJ
author Tina Skjørringe
Zeynep Tümer
Lisbeth Birk Møller
spellingShingle Tina Skjørringe
Zeynep Tümer
Lisbeth Birk Møller
Splice site mutations in the ATP7A gene.
PLoS ONE
author_facet Tina Skjørringe
Zeynep Tümer
Lisbeth Birk Møller
author_sort Tina Skjørringe
title Splice site mutations in the ATP7A gene.
title_short Splice site mutations in the ATP7A gene.
title_full Splice site mutations in the ATP7A gene.
title_fullStr Splice site mutations in the ATP7A gene.
title_full_unstemmed Splice site mutations in the ATP7A gene.
title_sort splice site mutations in the atp7a gene.
publisher Public Library of Science (PLoS)
series PLoS ONE
issn 1932-6203
publishDate 2011-04-01
description Menkes disease (MD) is caused by mutations in the ATP7A gene. We describe 33 novel splice site mutations detected in patients with MD or the milder phenotypic form, Occipital Horn Syndrome. We review these 33 mutations together with 28 previously published splice site mutations. We investigate 12 mutations for their effect on the mRNA transcript in vivo. Transcriptional data from another 16 mutations were collected from the literature. The theoretical consequences of splice site mutations, predicted with the bioinformatics tool Human Splice Finder, were investigated and evaluated in relation to in vivo results. Ninety-six percent of the mutations identified in 45 patients with classical MD were predicted to have a significant effect on splicing, which concurs with the absence of any detectable wild-type transcript in all 19 patients investigated in vivo. Sixty-seven percent of the mutations identified in 12 patients with milder phenotypes were predicted to have no significant effect on splicing, which concurs with the presence of wild-type transcript in 7 out of 9 patients investigated in vivo. Both the in silico predictions and the in vivo results support the hypothesis previously suggested by us and others, that the presence of some wild-type transcript is correlated to a milder phenotype.
url http://europepmc.org/articles/PMC3073976?pdf=render
work_keys_str_mv AT tinaskjørringe splicesitemutationsintheatp7agene
AT zeyneptumer splicesitemutationsintheatp7agene
AT lisbethbirkmøller splicesitemutationsintheatp7agene
_version_ 1724858332559179776